Umit Tapan, MD
Assistant Professor
Boston University School of Medicine
Dept of General Internal Medicine
Hematology & Medical Oncology

MD, Hacettepe University




Dr. Umit Tapan is an Assistant Professor of Medicine at Boston University School of Medicine and practicing Thoracic Oncologist at Boston Medical Center. His clinical interests are Non-small cell lung cancer, Small cell lung cancer, Mesothelioma, Immunotherapy, Targeted therapy/Precision Medicine. His research interests include Circulating tumor DNA, Gut microbiome and Cancer Immunotherapy, Racial Disparities in Cancer Care and Outcomes.

Dr. Tapan completed his fellowship in Hematology & Oncology at Boston Univesity Medical Center, in which he was Chief Fellow in Hematology & Oncology. Dr. Tapan completed his internship and residency at Steward Carney Hospital. He earned his medical degree from Hacettepe University School of Medicine, Ankara, Turkey.

Member
Boston University
BU-BMC Cancer Center


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kumaradevan S, Lee SY, Richards S, Lyle C, Zhao Q, Tapan U, Jiangliu Y, Ghumman S, Walker J, Belghasem M, Arinze N, Kuhnen A, Weinberg J, Francis J, Hartshorn K, Kolachalama VB, Cifuentes D, Rahimi N, Chitalia VC. c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/ß-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation. Am J Pathol. 2018 08; 188(8):1921-1933.View Related Profiles. PMID: 30029779; DOI: 10.1016/j.ajpath.2018.05.007;
     
  2. Tapan U, Lee SY, Weinberg J, Kolachalama VB, Francis J, Charlot M, Hartshorn K, Chitalia V. Racial differences in colorectal cancer survival at a safety net hospital. Cancer Epidemiol. 2017 08; 49:30-37.View Related Profiles. PMID: 28538169
     
  3. Shashar M, Siwak J, Tapan U, Lee SY, Meyer RD, Parrack P, Tan J, Khatami F, Francis J, Zhao Q, Hartshorn K, Kolachalama VB, Rahimi N, Chitalia V. c-Cbl mediates the degradation of tumorigenic nuclear ß-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors. Oncotarget. 2016 11 01; 7(44):71136-71150.View Related Profiles. PMID: 27661103; DOI: 10.18632/oncotarget.12107;
     
  4. Yuksel M, Yildiz A, Tapan U, Ertas F, Alan S. Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment. Arq Bras Cardiol. 2015 Dec; 105(6):642-6. PMID: 26761372
     
  5. Eliacik E, Yildirim T, Sahin U, Kizilarslanoglu C, Tapan U, Aybal-Kutlugun A, Hascelik G, Arici M. Potassium abnormalities in current clinical practice: frequency, causes, severity and management. Med Princ Pract. 2015; 24(3):271-5. PMID: 25766276; DOI: 10.1159/000376580;
     
  6. Pamuk GE, Uyanik MS, Top MS, Tapan U, Ak R, Uyanik V. Gastrointestinal symptoms are closely associated with depression in iron deficiency anemia: a comparative study. Ann Saudi Med. 2015 Jan-Feb; 35(1):31-5. PMID: 26142935; DOI: 10.5144/0256-4947.2015.31;
     
  7. Tapan U, Bolla S, Daglilar ES, Chang S, Kozyreva O. Outcome of patients with positive heparin-platelet factor-4 antibodies: A retrospective multi-institutional observational study. Platelets. 2015; 26(7):661-4. PMID: 25383658; DOI: 10.3109/09537104.2014.977243;
     
  8. Pamuk GE, Uyanik MS, Pamuk ON, Maden M, Tapan U. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis? Hematology. 2015 Jun; 20(5):267-71. PMID: 25271869; DOI: 10.1179/1607845414Y.0000000205;
     
  9. Tapan U, Ozbayrak M, Tatli S. MRI in local staging of rectal cancer: an update. Diagn Interv Radiol. 2014 Sep-Oct; 20(5):390-8. PMID: 25010367
     
  10. Tapan U, Pestana JB, Lee JC, Lerner A. Epstein-Barr virus-associated diffuse large B-cell lymphoma arising in atrial myxoma: a proposal for a modified therapeutic approach. Leuk Lymphoma. 2015 Feb; 56(2):505-7.View Related Profiles. PMID: 24794809; DOI: 10.3109/10428194.2014.919632;
     
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 19 publications over 10 distinct years, with a maximum of 5 publications in 2014

YearPublications
20082
20091
20101
20112
20122
20145
20153
20161
20171
20181

Contact for Mentoring:
Tapan's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department